POSEIDA THERAPEUTICS INC - Common Stock, par value $0.0001 per share (PSTX)

CUSIP: 73730P108

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
98,365,673
Total 13F shares
26,151,081
Share change
-1,724,067
Total reported value
$190,704,000
Put/Call ratio
17%
Price per share
$7.29
Number of holders
62
Value change
-$17,048,693
Number of buys
32
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 73730P108?
CUSIP 73730P108 identifies PSTX - POSEIDA THERAPEUTICS INC - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of POSEIDA THERAPEUTICS INC - Common Stock, par value $0.0001 per share (PSTX) as of Q3 2021

As of 30 Sep 2021, POSEIDA THERAPEUTICS INC - Common Stock, par value $0.0001 per share (PSTX) was held by 62 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,151,081 shares. The largest 10 holders included FMR LLC, Pentwater Capital Management LP, BlackRock Inc., VANGUARD GROUP INC, Aisling Capital Management LP, MILLENNIUM MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 62 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.